Kothari, C.; Clemenceau, A.; Ouellette, G.; Ennour-Idrissi, K.; Michaud, A.; Diorio, C.; Durocher, F.
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ? Cancers 2021, 13, 1726.
https://doi.org/10.3390/cancers13071726
AMA Style
Kothari C, Clemenceau A, Ouellette G, Ennour-Idrissi K, Michaud A, Diorio C, Durocher F.
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ? Cancers. 2021; 13(7):1726.
https://doi.org/10.3390/cancers13071726
Chicago/Turabian Style
Kothari, Charu, Alisson Clemenceau, Geneviève Ouellette, Kaoutar Ennour-Idrissi, Annick Michaud, Caroline Diorio, and Francine Durocher.
2021. "Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?" Cancers 13, no. 7: 1726.
https://doi.org/10.3390/cancers13071726
APA Style
Kothari, C., Clemenceau, A., Ouellette, G., Ennour-Idrissi, K., Michaud, A., Diorio, C., & Durocher, F.
(2021). Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ? Cancers, 13(7), 1726.
https://doi.org/10.3390/cancers13071726